A significant grant of ₹4.18 crore has been awarded to the Sanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGIMS) in Lucknow by the Indian Council of Medical Research (ICMR). This funding will enable researchers to delve into the genetic and pathological foundations of isolated congenital heart defects (ICHD). These are a prevalent form of heart malformation observed in newborns. Early detection is possible with modern diagnostic tools; however, the underlying causes are not yet fully understood.
Consequently, a research initiative from the stem cell research center within SGPGIMS’s hematology department aims to close this knowledge gap. They plan to thoroughly investigate the molecular and genetic basis of ICHD. Insights from this vital research could ultimately lead to more effective prevention strategies and enhanced treatments for affected infants. [2, 14]
Understanding Congenital Heart Defects in Newborns
Congenital heart defects represent the most common congenital anomaly, impacting millions globally. [2] In India, the estimated number of children born with congenital heart disease exceeds 200,000 annually. Approximately one-fifth of these cases may require intervention in their first year of life. [8, 9] The prevalence of congenital heart disease in the pediatric population across Central India varies, with some studies reporting rates as high as 27.7 per 1,000 in outpatient cases. [6] Challenges in pediatric cardiac care in India often include financial constraints, community health-seeking behaviors, and a general lack of awareness. [8]
Dr. Chandra Prakash Chaturvedi leads the SGPGIMS team that secured this substantial grant. Dr. Chaturvedi emphasizes that the project endeavors to preserve young lives. Moreover, by precisely identifying molecular patterns linked to isolated congenital heart defects, researchers hope to clarify biological mechanisms. They will furthermore help identify crucial genes and protein markers. Ultimately, the team plans to discover new targets for early diagnosis and regenerative therapies. [2, 14]
Advancing ICHD Research in India
The primary aim of this research is to discover early detection biomarkers and pioneer innovative treatments. This work will transform care for newborns diagnosed with ICHD. Subsequently, it will ensure healthier pregnancies and better long-term outcomes. SGPGIMS professors Mandakini Pradhan and Neeta Singh, from the department of maternal and reproductive health, will serve as co-principal investigators, bringing diverse expertise to this collaborative effort.
Congenital heart defects often have complex genetic underpinnings. Scientists have identified novel genetic interactions that can contribute to these conditions. This suggests that genetic interactions, rather than single-gene causes alone, play a significant role. [2] This new research at SGPGIMS builds upon the growing understanding of the genetic architecture of CHD. [14]
Frequently Asked Questions
Q1: What is the purpose of the ₹4.18 crore grant to SGPGIMS?
The grant aims to fund research into the genetic and pathological foundation of isolated congenital heart defects (ICHD) in newborns, seeking to bridge knowledge gaps and improve diagnostic and treatment strategies.
Q2: Who is leading the research project at SGPGIMS?
Dr. Chandra Prakash Chaturvedi is leading the research team, with Professors Mandakini Pradhan and Neeta Singh acting as co-principal investigators.
Q3: What are the expected outcomes of this ICHD research?
Researchers hope to clarify biological mechanisms, identify crucial genes and protein markers, discover new targets for early diagnosis and regenerative therapies, and ultimately find early detection biomarkers to transform care for newborns with ICHD.
References
- ₹4 crore grant to SGPGIMS to study ICHD – ETHealthworld
- Hidden genetic causes of congenital heart disease identified – M3 India
- Prevalence and Pattern of Congenital Heart Disease in Pediatric Population—A Study from Central India
- Congenital Heart Disease in India: A Status Report – PubMed
- Genetics of Congenital Heart Disease: The Glass Half Empty – PMC
Disclaimer: This article was automatically generated from publicly available sources and is provided for informational and educational purposes only. OC Academy does not exercise editorial control or claim authorship over this content. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider and refer to current local and national clinical guidelines.